Effect of active immunization against luteinizing hormone-releasing hormone on the androgen-sensitive dunning R3327-PAP and androgen-independent Dunning R3327-AT2.1 Prostate cancer sublines

Prostate

Volumn 32, Issue 2, 1997, Pages 77-84

  Fuerst, Johannes ^a   Fiebiger, Eduard ^a   Jungwirth, Andreas ^b   Mack, Doris ^b   Talwar, Pran G ^c   Frick, Julian ^b   Rovan, Erwin ^a  

^a UNIVERSITY OF SALZBURG   (Austria)

^b St Johanns Spital   (Austria)

^c NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

Author keywords

Active immunization; Dunning R3327 AT2.1; Dunning R3327 PAP; LHRH DT vaccine; Prostate cancer; Rat

Indexed keywords

ANDROGEN; DIPHTHERIA TOXOID; GONADORELIN; TESTOSTERONE; VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATROPHY; CELL DIVISION; CONTROLLED STUDY; DOWN REGULATION; DRUG CONJUGATION; IMMUNIZATION; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATE; PROSTATE ADENOCARCINOMA; RAT; TESTIS;

ANALYSIS OF VARIANCE; ANIMALS; CANCER VACCINES; CELL DIVISION; CELL LINE; CLONE CELLS; DIPHTHERIA TOXIN; FOLLICLE STIMULATING HORMONE; GONADOTROPIN-RELEASING HORMONE; IMMUNOTHERAPY; MALE; PROSTATE; PROSTATIC NEOPLASMS; RATS; RATS, INBRED F344; TESTIS; TESTOSTERONE; VACCINES, SYNTHETIC;

EID: 0030976445     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19970701)32:2<77::AID-PROS1>3.0.CO;2-C     Document Type: Article

References (20)

1. Goldspiel BR, Kohler DR: Goserelin acetate implant: A depot luteinizing hormone-releasing hormone analog for advanced prostate cancer. DICP 25:796-804, 1991.
2. 6-LH-RH. Med Oncol Tumor Pharmacother 1(2):109-118, 1983.
3. Yamamaka H, Imai K, Mashimo T, Yuasa H, Yoshida M, Asano M, Fukazaki H, KumaKura M: Fundamental study on the implantable LH-RH agonist/polymer and its use in a randomized trial for prostate cancer. EORTC Genitourin Group Monogr 7: 135-143, 1990.
4. Srkalovic G, Bokser L, Radulovic S, Korkut E, Schally AV: Receptors for luteinizing hormone-releasing hormone (LHRH) in Dunning R3327 prostate cancers and rat anterior pituitaries after treatment with a sustained delivery system of LHRH antagonist SB-75. Endocrinology 127:3052-3060, 1990.
5. Talwar GP: Immunobiology of gonadotropin-releasing hormone. J Steroid Biochem 23:795-800, 1985.
6. Rovan E, Fiebiger E, Kalla NR, Talwar GP, Aulitzky W, Frick J: Effect of active immunization to luteinizing hormone-releasing hormone on the fertility and histoarchitecture of the reproductive organs of male rat. Urol Res 20:323-334, 1992.
7. Fuerst J, Fiebiger E, Poetscher U, Mack D, Frick J, Rovan E: The effect of active immunization against gonadotropin-releasing hormone on the ultrastructure of the rat ventral prostate. Urol Res 22:107-113, 1994.
8. Kadar T, Ben David M, Pontes EJ, Fekete M, Schally AV: Prolactin and luteinizing hormone-releasing hormone receptors in human benign prostatic hyperplasia and prostate cancer. Prostate 12:299-307, 1988.
9. Limonta P, Dondi D, Moretti R, Fermo D, Garattini E, Motta M: Expression of luteinizing hormone-releasing hormone mRNA in the human prostatic cancer cell line LNCaP. J Clin Endocrinol Metab 76:797-800, 1993.
10. Maggi R, Moretti RM, Marelli MM, Pimpinelli F, Motta M: Human prostatic carcinoma cell line LNCaP degrades luteinizing hormone releasing hormone. Int J Oncol 6:1231-1234, 1995.
11. Qayum A, Gullik W, Clayton RC, Sikora K, Waxman I: The effects of gonadotrophin-releasing hormone analogues in prostatic cancer are mediated through specific tumor receptors. Br J Cancer 62:96-99, 1990.
12. Reddy PR, Rao IM, Raju W, Reddy RL: Direct inhibitory actions of LHRH on accessory reproductive organs of rat. J Steroid Biochem 23:819-822, 1985.
13. St-Arnaud R, Poyet P, Walker P, Labrie F: Androgens modulate epidermal growth factor level in the rat ventral prostate. Mol Cell Endocrinol 56:21-27, 1988.
14. Westin P, Stattin P, Damber J-E, Bergh A: Castration therapy rapidly induces apoptosis in a minority and decreases cell proliferation in a majority of human prostatic tumors. Am J Pathol 146:1368-1375, 1995.
15. Westin P, Bergh A, Damber J-E: Castration rapidly results in a major reduction in epithelial cell numbers in the rat prostate, but not in the highly differentiated Dunning R3327 prostatic adenocarcinoma. Prostate 22:65-74, 1993.
16. Westin P, Brändström A, Damber J-E, Bergh A: Castration plus oestrogen treatment induces but castration alone suppresses epithelial cell apoptosis in an androgen-sensitive rat prostatic adenocarcinoma. Br J Cancer 72:140-145, 1995.
17. Jayashankar R, Chaudhuri M, Singh O, Alam A, Talwar GP: Semisynthetic anti-LHRH vaccine causing atrophy of the prostate. Prostate 14:3-11, 1989.
18. Haavisto AM, Petterson K, Bergendahl M, Perheentupa A, Roser JF, Huhtaniemi L: A supersensitive immunofluorometric assay for rat luteinizing-hormone. Endocrinology 132:1678-1681, 1993.
19. Dunning WF: Prostate cancer in the rat. Monogr Natl Cancer Inst 12:351, 1963.
20. Isaacs JT, Isaacs WB, Feitz WFJ, Scheres J: Establishment and characterization of seven Dunning rat prostatic cancer cell lines and their use in developing methods for predicting metastatic abilities of proslatic cancers. Prostate 9:261, 1986.